AU2003230873A1 - Targeted cytocidal virionoids for antiangiogenesis - Google Patents

Targeted cytocidal virionoids for antiangiogenesis

Info

Publication number
AU2003230873A1
AU2003230873A1 AU2003230873A AU2003230873A AU2003230873A1 AU 2003230873 A1 AU2003230873 A1 AU 2003230873A1 AU 2003230873 A AU2003230873 A AU 2003230873A AU 2003230873 A AU2003230873 A AU 2003230873A AU 2003230873 A1 AU2003230873 A1 AU 2003230873A1
Authority
AU
Australia
Prior art keywords
virionoids
antiangiogenesis
cytocidal
targeted
targeted cytocidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230873A
Other versions
AU2003230873A8 (en
Inventor
Erlinda M. Gordon
Frederick L. Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU2003230873A1 publication Critical patent/AU2003230873A1/en
Publication of AU2003230873A8 publication Critical patent/AU2003230873A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/851—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from growth factors; from growth regulators

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003230873A 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis Abandoned AU2003230873A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37175902P 2002-04-11 2002-04-11
US60/371,759 2002-04-11
PCT/US2003/011142 WO2003087329A2 (en) 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis

Publications (2)

Publication Number Publication Date
AU2003230873A1 true AU2003230873A1 (en) 2003-10-27
AU2003230873A8 AU2003230873A8 (en) 2003-10-27

Family

ID=29250738

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230873A Abandoned AU2003230873A1 (en) 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis

Country Status (2)

Country Link
AU (1) AU2003230873A1 (en)
WO (1) WO2003087329A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037329A (en) * 1994-03-15 2000-03-14 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
IL132087A0 (en) * 1997-04-10 2001-03-19 Univ Southern California Modified proteins which bind extracellular matrix components
JP2002514388A (en) * 1998-04-29 2002-05-21 ユニバーシティー・オブ・サウザーン・カリフォルニア Retroviral vectors containing modified envelope escort proteins

Also Published As

Publication number Publication date
AU2003230873A8 (en) 2003-10-27
WO2003087329A2 (en) 2003-10-23
WO2003087329A3 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003217296A1 (en) Grouser
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003267638A1 (en) Endoscope
AU2003237159A1 (en) Treatment for phenylketonuria
AU2003235123A1 (en) Unit
AU2003283626A1 (en) Catheter
AU2003216053A1 (en) Guanidino compounds
AU2003272902A1 (en) Remedies
AU2003247005A1 (en) Therapy combination
AU2003238970A1 (en) Pain assessment
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003215150A1 (en) Therapeutic compounds
AU2002951396A0 (en) Horseshoe
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003228198A1 (en) Av-fistula bandage
AU2003272901A1 (en) Remedies
AU2003298582A1 (en) Therapeutic guanidines
AU2003209453A1 (en) Transposon
AU2003244140A1 (en) Catheter
AU2003257088A1 (en) Endoscope assembly
AU2003262152A1 (en) Endoscope
AU2003254611A1 (en) Scalpel
AU2003234867A1 (en) Rollator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase